|
Real-time Estimate
Tradegate
04:49:07 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 15.69 EUR | +1.51% |
|
+1.22% | +47.20% |
| 09-28 | Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance | MT |
| 09-28 | Mylan seeks to clear patent obstacle for generic Wegovy | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 20.22B | |||||
| 1,019B | |||||
| 617B | - | ||||
| 464B | |||||
| 356B | |||||
| 333B |
Select your edition
All financial news and data tailored to specific country editions
